GW pharmaceuticals Logo (WIPO, 02/28/2019)
WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark GW pharmaceuticals was filed as Figurative mark on 02/28/2019 at the World Intellectual Property Organization.
Logodesign (Wiener Klassifikation)
#Letters presenting a special form of writing #Series of letters presenting different forms of writing #Series of letters in different dimensions #Letters underlined, overlined, framed or barred by one or more strokes
| Trademark form | Figurative mark |
| File reference | 1462420 |
| Register number | UK00003355228 |
| Countries | 
|
| Base trademark |
No. UK00003355228,
February 8, 2019
|
| Application date | February 28, 2019 |
| Expiration date | February 28, 2029 |
Trademark owner
Sovereign House, Histon
Cambridge CB24 9BZ
GB
Cambridge CB24 9BZ
GB
Trademark representatives
Winthrop & Weinstine,
225 South Sixth Street,
US
goods and services
05
Pharmaceutical, medical and veterinary preparations and
substances; pharmaceutical preparations and substances for
the treatment of epilepsy; pharmaceutical preparations and
substances for the treatment of pediatric epilepsy;
pharmaceutical preparations and substances for the treatment
of convulsions, seizures, Dravet syndrome, Lennox-Gastaut
syndrome, intractable childhood epilepsy with generalized
tonic-clonic seizures, generalized epilepsy with febrile
seizures plus, Doose syndrome and chromosome disorders;
herbs for medicinal purposes; medicinal herbs; medicinal
oils; medicinal infusions; medicinal infusions for the
treatment of epilepsy, convulsions and seizures; pure
extracts of medicinal plants and herbs; foodstuffs for
medicinal purposes; dietary supplements for humans and
animals; dietetic food and substances adapted for medical or
veterinary use; food for babies; herb teas for medicinal
purposes; medications for the treatment of multiple
sclerosis, pain associated with cancer, neuropathies and
rheumatoid arthritis; medicines for the treatment of
symptoms including pain, muscle spasticity and spasms,
bladder problems and sleep disorders; medications for the
treatment of conditions to which neuropathic pain is
associated, including multiple sclerosis, cancer, spinal
cord injury, physical trauma and peripheral neuropathy
resulting from diabetes; medicines for the treatment of
anorexia-cachexia, the result of cancer or AIDS, and nausea,
and secondary vomiting due to chemotherapy treatments
31
Agricultural and horticultural products; seeds; seedlings
for plant breeding; flowers; plants; plant residues (raw
materials); fresh herbs; foodstuffs and beverages for
animals
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| November 26, 2020 | 2020/49 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| September 1, 2020 | 2020/36 Gaz | KR | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| July 16, 2020 | 2020/33 Gaz | MX | Rejection |
| June 25, 2020 | 2020/26 Gaz | JP | Rejection |
| June 1, 2020 | 2020/28 Gaz | IL | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| May 19, 2020 | 2020/21 Gaz | CO | Rejection |
| March 2, 2020 | 2020/10 Gaz | KR | Rejection |
| December 4, 2019 | 2019/49 Gaz | TR | Rejection |
| November 25, 2019 | 2019/48 Gaz | IN | Rejection |
| October 29, 2019 | 2019/45 Gaz | IL | Rejection |
| October 17, 2019 | 2019/42 Gaz | AU | Rejection |
| September 3, 2019 | 2019/36 Gaz | NZ | Rejection |
| February 28, 2019 | 2019/15 Gaz | GB | Registration |
ID: 141462420